ISSN 2736-1756
Advanced Journal of Microbiology Research ISSN 2241-9837 Vol. 13 (5), pp. 001-007, May, 2019. © International Scholars Journals
Full Length Research Paper
The immune-response enveloped-virus treatment for H22 ascitic tumors in mice
Mintao Zhong, Min Huang*, Lei Liu, Xiaoli Wang, Xingyun Li, Anhong Ning and Jing Cao
Department of Medical Microbiology, Dalian Medical University, 9 Western Section, Lvshun South Road, Lvshunkou District, Dalian 116044, China.
Accepted 23 March, 2019
Abstract
In addition to the standard therapies of chemotherapies and surgical interventions, viral therapy for tumor treatment has provided a new option for cancer patients. Whether the effects are safe, however, remains to be fully evaluated. Accordingly, we explored the immunological mechanisms of viral action against the H22 ascitic tumor, using both the Newcastle disease virus (NDV) and the parainfluenza virus (PIV). We measured IL-2 levels, Natural killer (NK) cell activity, lymphocyte proliferation rates, and the CD4+/CD8+ cell numbers' ratio. All indicators were superior in the virus-treatment group compared with the control group. Tumor cells infected by either virus induced the expression of the tumor-associated antigen, which stimulated the host immune system.
Key words: Immunologic mechanism, tumor immunity, viral immunotherapy, tumor-associated antigen.